Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Biochem Biophys ; 562: 1-8, 2014 Nov 15.
Article in English | MEDLINE | ID: mdl-25151305

ABSTRACT

Elevation in [Ca(2+)]i and activation of calpain-1 occur in central nervous system of SOD1(G93A) transgenic mice model of amyotrophic lateral sclerosis (ALS), but few data are available about the early stage of ALS. We here investigated the level of activation of the Ca(2+)-dependent protease calpain-1 in spinal cord of SOD1(G93A) mice to ascertain a possible role of the protease in the aetiology of ALS. Comparing the events occurring in the 120 day old mice, we found that [Ca(2+)]i and activation of calpain-1 were also increased in the spinal cord of 30 day old mice, as indicated by the digestion of some substrates of the protease such as nNOS, αII-spectrin, and the NR2B subunit of NMDA-R. However, the digestion pattern of these proteins suggests that calpain-1 may play different roles depending on the phase of ALS. In fact, in spinal cord of 30 day old mice, activation of calpain-1 produces high amounts of nNOS active species, while in 120 day old mice enhanced-prolonged activation of calpain-1 inactivates nNOS and down-regulates NR2B. Our data reveal a critical role of calpain-1 in the early phase and during progression of ALS, suggesting new therapeutic approaches to counteract its onset and fatal course.


Subject(s)
Amyotrophic Lateral Sclerosis/genetics , Calcium/metabolism , Calpain/metabolism , Nitric Oxide Synthase Type I/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Spinal Cord/metabolism , Amyotrophic Lateral Sclerosis/physiopathology , Animals , Disease Models, Animal , Disease Progression , Humans , Mice , Mice, Transgenic , Motor Neurons/metabolism , Nitric Oxide Synthase Type I/genetics , Proteolysis , Receptors, N-Methyl-D-Aspartate/genetics , Superoxide Dismutase/genetics , Superoxide Dismutase-1
3.
Mol Psychiatry ; 19(4): 433-43, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24535456

ABSTRACT

Stress and glucocorticoids alter glutamatergic transmission, and the outcome of stress may range from plasticity enhancing effects to noxious, maladaptive changes. We have previously demonstrated that acute stress rapidly increases glutamate release in prefrontal and frontal cortex via glucocorticoid receptor and accumulation of presynaptic SNARE complex. Here we compared the ex vivo effects of acute stress on glutamate release with those of in vitro application of corticosterone, to analyze whether acute effect of stress on glutamatergic transmission is mediated by local synaptic action of corticosterone. We found that acute stress increases both the readily releasable pool (RRP) of vesicles and depolarization-evoked glutamate release, while application in vitro of corticosterone rapidly increases the RRP, an effect dependent on synaptic receptors for the hormone, but does not induce glutamate release for up to 20 min. These findings indicate that corticosterone mediates the enhancement of glutamate release induced by acute stress, and the rapid non-genomic action of the hormone is necessary but not sufficient for this effect.


Subject(s)
Corticosterone/metabolism , Frontal Lobe/pathology , Neurons/pathology , Presynaptic Terminals/metabolism , Stress, Psychological/pathology , Analysis of Variance , Animals , Aspartic Acid/metabolism , Corticosterone/pharmacology , Dose-Response Relationship, Drug , Electroshock/adverse effects , Excitatory Postsynaptic Potentials/drug effects , In Vitro Techniques , Male , Neurons/metabolism , Presynaptic Terminals/drug effects , Rats , Rats, Sprague-Dawley , Signal Transduction/drug effects , Stress, Psychological/etiology , Synapsins/metabolism , Synaptic Vesicles/drug effects , Synaptic Vesicles/metabolism , Synaptosomes/metabolism , Tritium/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...